Stay updated on Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedFooter updates include adding Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure link along with the prior Revision: v3.3.2 reference. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not all be about the study. Page revision updated to v3.3.2, replacing the older wording about PubMed-derived listings.SummaryDifference0.1%

- Check54 days agoChange DetectedThe government funding lapse notice banner was removed from the page, eliminating the disclaimer about potential information delays. The notice previously warned that information may not be up to date and inquiries could be delayed until appropriations were enacted.SummaryDifference0.4%

- Check68 days agoChange DetectedThe old and new pages contain the same study record with unchanged core sections such as eligibility criteria, outcomes, locations, and contacts; any differences are limited to formatting and layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check97 days agoChange Detected- Added a government-operation notice and status links, clarifying potential delays and current NIH Clinical Center openness. - Removed the previous version tag (v3.1.0) and introduced v3.2.0.SummaryDifference3%

- Check104 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no substantive content changes.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page.